purpose evaluate tolerance effectiveness carbon ion radiotherapy patients unresectable bone soft tissue sarcomas patients methods conducted phase dose escalation study carbon ion radiotherapy patients NUMBER sites bone soft tissue sarcomas suited resection received carbon ion radiotherapy tumors involved spine paraspinous soft tissues NUMBER patients pelvis NUMBER patients extremities patients total dose ranged NUMBER NUMBER gray equivalent gye administered NUMBER fixed fractions NUMBER weeks NUMBER NUMBER median tumor size NUMBER cm3 range NUMBER NUMBER cm3 minimum NUMBER months results seven NUMBER patients treated highest total dose NUMBER gye experienced radiation therapy oncology group grade NUMBER acute skin reactions dose escalation halted level severe acute reactions grade NUMBER observed series overall local control rates NUMBER NUMBER NUMBER year NUMBER years respectively median survival time NUMBER months range NUMBER NUMBER months overall survival rates NUMBER NUMBER respectively conclusion carbon ion radiotherapy safe effective modality management bone soft tissue sarcomas eligible surgical resection providing good local control offering survival advantage unacceptable morbidity fifty seven follow follow NUMBER NUMBER year ii gye fraction